Cargando…
Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long‐term follow‐up and review of the literature
Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disease caused by deficiency of arylsulfatase A (ARSA). Heterozygous carriers of disease‐causing variants and individuals harbouring pseudodeficiency alleles in the ARSA gene exhibit reduced ARSA activity. In the context...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259399/ https://www.ncbi.nlm.nih.gov/pubmed/35822086 http://dx.doi.org/10.1002/jmd2.12293 |
_version_ | 1784741771607015424 |
---|---|
author | Laugwitz, Lucia Santhanakumaran, Vidiyaah Spieker, Mareike Boehringer, Judith Bender, Benjamin Gieselmann, Volkmar Beck‐Woedl, Stefanie Bruchelt, Gernot Harzer, Klaus Kraegeloh‐Mann, Ingeborg Groeschel, Samuel |
author_facet | Laugwitz, Lucia Santhanakumaran, Vidiyaah Spieker, Mareike Boehringer, Judith Bender, Benjamin Gieselmann, Volkmar Beck‐Woedl, Stefanie Bruchelt, Gernot Harzer, Klaus Kraegeloh‐Mann, Ingeborg Groeschel, Samuel |
author_sort | Laugwitz, Lucia |
collection | PubMed |
description | Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disease caused by deficiency of arylsulfatase A (ARSA). Heterozygous carriers of disease‐causing variants and individuals harbouring pseudodeficiency alleles in the ARSA gene exhibit reduced ARSA activity. In the context of these genotypes, low ARSA activity has been suggested to lead to an atypical form of MLD or other neurological abnormalities, but data are limited. The aim of our study was to analyse the impact of low ARSA activity in two subjects who are heterozygous for the ARSA pseudodeficiency allele and a disease‐causing variant. Biochemical testing included ARSA activity measurements and urinary sulfatide analysis. Biochemical data of a large cohort of MLD patients, heterozygotes, pseudodeficient individuals and healthy controls were analysed. MRI was performed at 3T using T1‐ and T2‐weighted sequences and MR spectroscopy. We present two long‐term follow‐ups who are heterozygous for the ARSA pseudodeficiency allele and a disease‐causing variant in the ARSA gene in cis. The two related index cases exhibit markedly reduced ARSA activity compared to controls and heterozygous carriers. The neurological evaluation and MRI do not reveal any abnormalities. Our data underline that extremely low enzyme activity due to a pseudodeficiency allele and a disease‐causing variant in the ARSA gene even in cis does not lead to clinical symptoms or pre‐symptomatic MRI changes suspicious for MLD. The review of literature corroborates that any association of low ARSA activity with disease features remains questionable. It seems important to combine the measurement of ARSA activity with elevated sulfatide as well as genetic testing, as done in current newborn screening approaches. Heterozygosity for metachromatic leukodystrophy and an arylsulfatase A pseudodeficiency allele does not cause neurological or neuropsychiatric features. |
format | Online Article Text |
id | pubmed-9259399 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92593992022-07-11 Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long‐term follow‐up and review of the literature Laugwitz, Lucia Santhanakumaran, Vidiyaah Spieker, Mareike Boehringer, Judith Bender, Benjamin Gieselmann, Volkmar Beck‐Woedl, Stefanie Bruchelt, Gernot Harzer, Klaus Kraegeloh‐Mann, Ingeborg Groeschel, Samuel JIMD Rep Case Reports Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disease caused by deficiency of arylsulfatase A (ARSA). Heterozygous carriers of disease‐causing variants and individuals harbouring pseudodeficiency alleles in the ARSA gene exhibit reduced ARSA activity. In the context of these genotypes, low ARSA activity has been suggested to lead to an atypical form of MLD or other neurological abnormalities, but data are limited. The aim of our study was to analyse the impact of low ARSA activity in two subjects who are heterozygous for the ARSA pseudodeficiency allele and a disease‐causing variant. Biochemical testing included ARSA activity measurements and urinary sulfatide analysis. Biochemical data of a large cohort of MLD patients, heterozygotes, pseudodeficient individuals and healthy controls were analysed. MRI was performed at 3T using T1‐ and T2‐weighted sequences and MR spectroscopy. We present two long‐term follow‐ups who are heterozygous for the ARSA pseudodeficiency allele and a disease‐causing variant in the ARSA gene in cis. The two related index cases exhibit markedly reduced ARSA activity compared to controls and heterozygous carriers. The neurological evaluation and MRI do not reveal any abnormalities. Our data underline that extremely low enzyme activity due to a pseudodeficiency allele and a disease‐causing variant in the ARSA gene even in cis does not lead to clinical symptoms or pre‐symptomatic MRI changes suspicious for MLD. The review of literature corroborates that any association of low ARSA activity with disease features remains questionable. It seems important to combine the measurement of ARSA activity with elevated sulfatide as well as genetic testing, as done in current newborn screening approaches. Heterozygosity for metachromatic leukodystrophy and an arylsulfatase A pseudodeficiency allele does not cause neurological or neuropsychiatric features. John Wiley & Sons, Inc. 2022-05-04 /pmc/articles/PMC9259399/ /pubmed/35822086 http://dx.doi.org/10.1002/jmd2.12293 Text en © 2022 The Authors. JIMD Reports published by John Wiley & Sons Ltd on behalf of SSIEM. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Laugwitz, Lucia Santhanakumaran, Vidiyaah Spieker, Mareike Boehringer, Judith Bender, Benjamin Gieselmann, Volkmar Beck‐Woedl, Stefanie Bruchelt, Gernot Harzer, Klaus Kraegeloh‐Mann, Ingeborg Groeschel, Samuel Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long‐term follow‐up and review of the literature |
title | Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long‐term follow‐up and review of the literature |
title_full | Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long‐term follow‐up and review of the literature |
title_fullStr | Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long‐term follow‐up and review of the literature |
title_full_unstemmed | Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long‐term follow‐up and review of the literature |
title_short | Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long‐term follow‐up and review of the literature |
title_sort | extremely low arylsulfatase a enzyme activity does not necessarily cause symptoms: a long‐term follow‐up and review of the literature |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259399/ https://www.ncbi.nlm.nih.gov/pubmed/35822086 http://dx.doi.org/10.1002/jmd2.12293 |
work_keys_str_mv | AT laugwitzlucia extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature AT santhanakumaranvidiyaah extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature AT spiekermareike extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature AT boehringerjudith extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature AT benderbenjamin extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature AT gieselmannvolkmar extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature AT beckwoedlstefanie extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature AT brucheltgernot extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature AT harzerklaus extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature AT kraegelohmanningeborg extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature AT groeschelsamuel extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature |